Up to 50% of older patients with atrial fibrillation do not receive recommended systemic anticoagulation, most commonly due to physician concerns about fall risk and associated bleeding.
Guidelines for managing atrial fibrillation recommend systemic anticoagulation for almost all patients age 65 and older, but in practice up to 50% of older patients do not receive maintenance anticoagulation therapy. The most common reason physicians cite for withholding anticoagulation in older patients with atrial fibrillation is a perception of a high risk of falling and associated bleeding, especially intracranial hemorrhage.
Hagerty et al. (Sun,) conducted a review in Atrial fibrillation. Systemic anticoagulation was evaluated. Up to 50% of older patients with atrial fibrillation do not receive recommended systemic anticoagulation, most commonly due to physician concerns about fall risk and associated bleeding.